← Back to Clinical Trials
Recruiting Phase 4 NCT06333145
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
Trial Parameters
Condition Effect of Drug
Sponsor Tongji Hospital
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 165
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-02-04
Completion 2025-12-31
Interventions
Remimazolam
Brief Summary
Exploring the ED90 of remimazolam in Drug-induced Sleep Endoscopy in adults at different BMI groups.
Eligibility Criteria
Inclusion Criteria: * 1\. Age 18-65 years old, 2. ASA Ⅰ-Ⅲ level; 3. Sign an informed consent form. Exclusion Criteria: * 1.A history of central nervous system diseases, cognitive disorders, mental disorders, or communication disorders; 2.serious cardiovascular, respiratory, liver or kidney disease; 3.Anticipated need for tracheal intubation or laryngeal mask; 4.Allergic to benzodiazepines and opioids; 5.Those who have taken sedative, analgesic or antidepressant drugs within 24 hours; 6.Abnormal liver and kidney function; 7.Recently participated in other clinical studies.